We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.5B
AUM Growth
-$470M
Cap. Flow
-$219M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.85%
Holding
751
New
67
Increased
353
Reduced
251
Closed
53

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$364M
2
VRT icon
Vertiv
VRT
+$292M
3
FITB
Fifth Third Bancorp
FITB
+$274M
4
DINO icon
HF Sinclair
DINO
+$253M
5
TGNA
TEGNA Inc
TGNA
+$211M

Sector Composition

Rank Sector Weight
1 Financials 18.6%
2 Healthcare 16.65%
3 Technology 14.96%
4 Industrials 14.22%
5 Energy 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETR icon
101
Entergy
ETR
$54.1B
$289M 0.35%
4,941,988
+126,748
+3% +$6.94M
UNP icon
102
Union Pacific
UNP
$183B
$288M 0.35%
1,057,035
-6,576
-0.6% -$1.66M
HCA icon
103
HCA Healthcare
HCA
$84.8B
$282M 0.34%
1,123,394
+276,890
+33% +$69.5M
EFOR
104
Everforth Inc
EFOR
$845M
$281M 0.34%
2,413,449
+27,829
+1% +$3.15M
AMGN icon
105
Amgen
AMGN
$203B
$279M 0.34%
1,154,401
+19,366
+2% +$4.45M
CNI icon
106
Canadian National Railway
CNI
$78.3B
$276M 0.33%
2,058,293
-690,207
-25% -$86.3M
SLM icon
107
SLM Corp
SLM
$4.57B
$274M 0.33%
14,965,786
+4,042,189
+37% +$76.4M
UHS icon
108
Universal Health Services
UHS
$9.43B
$272M 0.33%
1,874,797
-158,262
-8% -$21.9M
PII icon
109
Polaris
PII
$4.15B
$271M 0.33%
2,569,858
-826,600
-24% -$94.2M
OTIS icon
110
Otis Worldwide
OTIS
$27.4B
$270M 0.33%
3,511,549
+333,471
+10% +$26.7M
CW icon
111
Curtiss-Wright
CW
$27.7B
$267M 0.32%
1,779,996
-297,287
-14% -$42.3M
EQR icon
112
Equity Residential
EQR
$25.4B
$263M 0.32%
2,919,620
-257,920
-8% -$22.8M
WCC
113
WESCO International
WCC
$16.2B
$261M 0.32%
2,018,687
-32,511
-2% -$4.07M
RHI icon
114
Robert Half
RHI
$3.61B
$261M 0.32%
2,285,650
-434,723
-16% -$50.1M
REG icon
115
Regency Centers
REG
$15B
$260M 0.31%
3,644,470
+121,137
+3% +$8.48M
CCK icon
116
Crown Holdings
CCK
$12.8B
$259M 0.31%
2,073,165
+49,829
+2% +$5.89M
CHKP icon
117
Check Point Software Technologies
CHKP
$13.3B
$259M 0.31%
1,873,144
+1,862,359
+17,268% +$243M
HAS icon
118
Hasbro
HAS
$12.6B
$258M 0.31%
3,145,640
+713,710
+29% +$66.9M
ORCL icon
119
Oracle
ORCL
$331B
$255M 0.31%
3,078,674
+1,355,182
+79% +$110M
WH icon
120
Wyndham Hotels & Resorts
WH
$5.46B
$254M 0.31%
2,998,275
+41,752
+1% +$3.56M
GL icon
121
Globe Life
GL
$13.5B
$251M 0.3%
2,493,163
-23,725
-0.9% -$2.41M
FLEX icon
122
Flex
FLEX
$43.4B
$246M 0.3%
17,600,151
+2,476,661
+16% +$31.6M
PFE icon
123
Pfizer
PFE
$140B
$243M 0.29%
4,682,985
-172,459
-4% -$8.95M
CAT icon
124
Caterpillar
CAT
$409B
$241M 0.29%
1,084,953
-252,361
-19% -$52.9M
NXST icon
125
Nexstar Media Group
NXST
$5.6B
$241M 0.29%
1,281,140
+51,990
+4% +$9.04M

Similar funds

Boston Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Boston Partners held 751 positions worth $82.5B, down 0.57% from $83B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Partners's Q1 2022 filing shows 67 new, 353 increased, 251 reduced and 53 closed positions. Its largest new stake was Microchip Technology: 4,127,908 shares worth $310M. The largest sale was Citigroup, an estimated $364M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Partners's largest Q1 2022 buy was Microchip Technology: 4,127,908 shares worth $310M.
  • Boston Partners added most to Procter & Gamble in Q1 2022, an estimated $531M increase.
  • Boston Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $364M.
  • Boston Partners fully exited Vertiv in Q1 2022, selling an estimated $292M.
  • Boston Partners's ten largest holdings make up 14% of its $82.5B portfolio in Q1 2022.
  • Boston Partners opened 67 new positions and closed 53 in Q1 2022.
  • Boston Partners's portfolio value fell 0.57% quarter-over-quarter to $82.5B.

Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.